SecBot SecBot
SECBOTREPLAY Home › Report › HALO

HALO · Two HALO directors sold a combined $624K in open-market sales over a…

HALOZYME THERAPEUTICS, INC. · CLUSTER filed Jul 2, 2026 at 16:42 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Jul 2, 2026 at 16:42 ET

Two HALO directors sold a combined $624K in open-market sales over a 3-day window, with the bulk ($548K) from Director Krishnan Mahesh following a derivative exercise. The total sales represent ~0.007% of HALO's $9.1B market cap, a trivial amount. The cluster is dominated by non-cash grants/awards to the CFO and EVP, which carry no economic signal. The open-market sales are small relative to company size and are likely routine portfolio diversification.

  • Two directors sold a combined $624K in open-market sales over a 3-day window (June 29, July 1, 2026).
  • Total open-market sales represent ~0.007% of HALO's $9.1B market cap, a trivial amount.
  • The cluster is dominated by non-cash grants/awards to the CFO and EVP (208,041 shares at $0), which carry no economic signal.
  • Director Krishnan Mahesh's sale ($548K) followed a derivative exercise, a common pattern for tax diversification, not a bearish signal.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access